BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22826156)

  • 1. Simulating from marginal structural models with time-dependent confounding.
    Havercroft WG; Didelez V
    Stat Med; 2012 Dec; 31(30):4190-206. PubMed ID: 22826156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect modification by time-varying covariates.
    Robins JM; Hernán MA; Rotnitzky A
    Am J Epidemiol; 2007 Nov; 166(9):994-1002; discussion 1003-4. PubMed ID: 17875581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correcting for Measurement Error in Time-Varying Covariates in Marginal Structural Models.
    Kyle RP; Moodie EE; Klein MB; Abrahamowicz M
    Am J Epidemiol; 2016 Aug; 184(3):249-58. PubMed ID: 27416840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.
    Hernán MA; Brumback BA; Robins JM
    Stat Med; 2002 Jun; 21(12):1689-709. PubMed ID: 12111906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyzing direct and indirect effects of treatment using dynamic path analysis applied to data from the Swiss HIV Cohort Study.
    Røysland K; Gran JM; Ledergerber B; von Wyl V; Young J; Aalen OO
    Stat Med; 2011 Oct; 30(24):2947-58. PubMed ID: 21800346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studies.
    Suarez D; Haro JM; Novick D; Ochoa S
    J Clin Epidemiol; 2008 Jun; 61(6):525-30. PubMed ID: 18471655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History-adjusted marginal structural models for estimating time-varying effect modification.
    Petersen ML; Deeks SG; Martin JN; van der Laan MJ
    Am J Epidemiol; 2007 Nov; 166(9):985-93. PubMed ID: 17875580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Time-dependent confounding in the estimation of treatment effects in randomised trials with multimodal therapies--an illustration of the problem of time-dependent confounding by causal graphs].
    Zietemann VD; Schuster T; Duell TH
    Gesundheitswesen; 2015 Jan; 77(1):62-6. PubMed ID: 24203687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of conventional and marginal structural Cox model estimators: a simulation study.
    Xiao Y; Abrahamowicz M; Moodie EE
    Int J Biostat; 2010; 6(2):Article 13. PubMed ID: 21969997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent confounding in the study of the effects of regular physical activity in chronic obstructive pulmonary disease: an application of the marginal structural model.
    Garcia-Aymerich J; Lange P; Serra I; Schnohr P; Antó JM
    Ann Epidemiol; 2008 Oct; 18(10):775-83. PubMed ID: 18708291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of longitudinal marginal structural models.
    Bryan J; Yu Z; Van Der Laan MJ
    Biostatistics; 2004 Jul; 5(3):361-80. PubMed ID: 15208200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal structural models for estimating effect modification.
    Chiba Y; Azuma K; Okumura J
    Ann Epidemiol; 2009 May; 19(5):298-303. PubMed ID: 19362275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.
    Brumback BA; Hernán MA; Haneuse SJ; Robins JM
    Stat Med; 2004 Mar; 23(5):749-67. PubMed ID: 14981673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural accelerated failure time models for survival analysis in studies with time-varying treatments.
    Hernán MA; Cole SR; Margolick J; Cohen M; Robins JM
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):477-91. PubMed ID: 15660442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accounting for baseline differences and measurement error in the analysis of change over time.
    Braun J; Held L; Ledergerber B;
    Stat Med; 2014 Jan; 33(1):2-16. PubMed ID: 23900718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A marginal structural model for multiple-outcome survival data:assessing the impact of injection drug use on several causes of death in the Canadian Co-infection Cohort.
    Moodie EE; Stephens DA; Klein MB
    Stat Med; 2014 Apr; 33(8):1409-25. PubMed ID: 24272681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating causal treatment effects from longitudinal HIV natural history studies using marginal structural models.
    Ko H; Hogan JW; Mayer KH
    Biometrics; 2003 Mar; 59(1):152-62. PubMed ID: 12762452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensemble learning of inverse probability weights for marginal structural modeling in large observational datasets.
    Gruber S; Logan RW; Jarrín I; Monge S; Hernán MA
    Stat Med; 2015 Jan; 34(1):106-17. PubMed ID: 25316152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.